RBOT
Vicarious Surgical Inc.
NYSE: RBOT · HEALTHCARE · MEDICAL DEVICES
$0.50
-9.09% today
Updated 2026-04-30
Market cap
$3.92M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.19
Dividend yield
—
52W range
$0 – $14
Volume
0.1M
Vicarious Surgical Inc. (RBOT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — |
| Cost of revenue | — | — | $316000.00 | $1.94M | $1.85M | $2.11M | $1.43M |
| Gross profit | — | — | $-316000.00 | $-1.94M | $-1.85M | $-2.11M | $-1.43M |
| Gross margin | — | — | — | — | — | — | — |
| R&D | $7.48M | $9.80M | $22.06M | $43.90M | $47.58M | $40.16M | $33.60M |
| SG&A | $2.05M | $2.33M | $13.20M | $29.71M | $26.86M | $21.88M | $15.20M |
| Operating income | $-9.78M | $-12.98M | $-38.22M | $-80.08M | $-80.67M | $-66.56M | $-50.97M |
| Operating margin | — | — | — | — | — | — | — |
| EBITDA | $-9.68M | $-12.83M | $-34.80M | $6.47M | $-69.19M | $-61.12M | $-49.54M |
| EBITDA margin | — | — | — | — | — | — | — |
| EBIT | $-9.78M | $-12.98M | $-35.12M | $5.36M | $-71.05M | $-63.22M | $-50.97M |
| Interest expense | $0.00 | $3000.00 | $89000.00 | $200000.00 | $25000.00 | $0.00 | — |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-9.31M | $-12.88M | $-35.21M | $5.16M | $-71.07M | $-63.22M | $-50.18M |
| Net income growth (YoY) | — | -38.2% | -173.5% | +114.6% | -1478.1% | +11.0% | +20.6% |
| Profit margin | — | — | — | — | — | — | — |